Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Stanford University
AstraZeneca
VA Office of Research and Development
Eli Lilly and Company
Genentech, Inc.
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
Pfizer
pharmaand GmbH
M.D. Anderson Cancer Center
Genmab
Revolution Medicines, Inc.
Pfizer
Incyte Corporation
Seagen Inc.
Seagen Inc.
Gilead Sciences
Seagen Inc.
Hoffmann-La Roche
University of Kansas Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Altor BioScience
GlaxoSmithKline